Literature DB >> 25160587

miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.

Xin Chen1, Bin Hao, Guosheng Han, Ying Liu, Dongwei Dai, Yanan Li, Xi Wu, Xiaoping Zhou, Zhijian Yue, Laixing Wang, Yiqun Cao, Jianmin Liu.   

Abstract

MicroRNAs are known to be involved in carcinogenesis and tumor progression in glioma. Recently, microRNA-372 (miR-372) has been proved to play a substantial role in several human cancers, but its functions in glioma remain unclear. In this study, we confirmed that miR-372 was commonly upregulated in glioma cell lines and tissues. Downregulation of miR-372 markedly inhibited cell proliferation and invasion and induced G1/S arrest and apoptosis. Consistently, the xenograft mouse model also unveiled the suppressive effects of miR-372 knockdown on tumor growth. Further studies revealed that miR-372 modulated the expression of PHLPP2 by directly targeting its 3'-untranslated region (3'-UTR) and that miR-372 expression was inversely correlated with PHLPP2 expression in glioma samples. Silencing of PHLPP2 could rescue the inhibitory effect of miR-372 inhibitor. Moreover, miR-372 knockdown suppressed the phosphorylation levels of the major components of PI3K/Akt pathway including Akt, mTOR, and P70S6K. Taken together, our results suggest that miR-372 functions as an oncogenic miRNA through targeting PHLPP2 in glioma.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLIOMA; INVASION; PHLPP2; PROLIFERATION; miR-372

Mesh:

Substances:

Year:  2015        PMID: 25160587     DOI: 10.1002/jcb.24949

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  18 in total

1.  MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.

Authors:  Chengshan Xu; Ling Zhang; Hengheng Li; Zhihua Liu; Lianning Duan; Chengrong Lu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.

Authors:  Xia Cui; Qingyan Li; Yukai He
Journal:  Mol Cell Biochem       Date:  2016-11-07       Impact factor: 3.396

3.  MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.

Authors:  Yang Li; Yunqian Li; Pengfei Ge; Chengyuan Ma
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

4.  miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma.

Authors:  Xuan Huang; Mingjie Huang; Lingbao Kong; Yong Li
Journal:  Cell Prolif       Date:  2015-10       Impact factor: 6.831

5.  microRNA‑372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1.

Authors:  Ya-Xin Zhao; Hua-Cheng Liu; Wei-Yang Ying; Cheng-Yu Wang; Yao-Jun Yu; Wei-Jian Sun; Jie-Fan Liu
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

6.  HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.

Authors:  Jiahui An; Jie Xu; Jiao Li; Song Jia; Xiaonan Li; Yanan Lu; Yuxin Yang; Zhuojia Lin; Xiaoru Xin; Mengying Wu; Qidi Zheng; Hu Pu; Xin Gui; Tianming Li; Dongdong Lu
Journal:  Oncotarget       Date:  2017-07-25

7.  MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma.

Authors:  Qing Wang; Siyang Liu; Xitong Zhao; Yuan Wang; Dali Tian; Wenjun Jiang
Journal:  Cancer Med       Date:  2017-04-24       Impact factor: 4.452

Review 8.  Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma.

Authors:  Alfred Buhagiar; Duncan Ayers
Journal:  Anal Cell Pathol (Amst)       Date:  2015-07-14       Impact factor: 2.916

9.  PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells.

Authors:  Alena J Smith; Yang-An Wen; Payton D Stevens; Jingpeng Liu; Chi Wang; Tianyan Gao
Journal:  Oncotarget       Date:  2016-02-16

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.